Massachusetts Institute of Technology
MIT is an AWE facility from 1942-1946 and a beryllium vendor facility from 1943-1946 so workers are eligible to file Part B claims during the appropriate years.
MIT has a Special Exposure Cohort for workers with specific cancers and at least 250 days employment from May 9, 1946-December 31, 1963.
The Massachusetts Institute of Technology (MIT) began experimental work on producing uranium metal in the spring of 1942 using a process involving melting and casting. It is this uranium metallurgical work which took place on the MIT campus by MIT employees that supports its designation as an Atomic Weapons Employer (AWE).
MIT is also designated as a beryllium vendor. MIT's work with beryllium was known as the "Metallurgical Project" and started when it entered into a research and development contract with the Manhattan Engineer District (MED). The Metallurgical Project involved studying the characteristics of beryllium metal and attempting to make a satisfactory beryllium-uranium alloy. In addition, beryllium oxide crucibles were made for use by the MED.
After a number of its employees contracted beryllium disease, MIT consolidated the activities described above in an off-campus site known as the Hood Building, which is a separate covered facility under the EEOICPA. The transition to the Hood Building was complete by the fall of 1946.
DOE lists MIT as a covered EEOICPA facility.
DOL provides Part B statistics for MIT.
NIOSH lists statistics for MIT dose reconstructions.